We would love to hear your thoughts about our site and services, please take our survey here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksJUS.L Regulatory News (JUS)

  • There is currently no data for JUS

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Edison reviews Jupiter US Smaller Companies (JUS)

17 May 2018 14:03

RNS Number : 4649O
Jupiter US Smaller Companies PLC
17 May 2018
 

 

London, UK, 17 May 2018

Edison issues review on Jupiter US Smaller Companies (JUS)

Jupiter US Smaller Companies (JUS) aims to generate long-term capital growth from a focused portfolio of mid- and small-cap US equities. Since 2001, the trust has been managed by Robert Siddles. Following the announcement of adjustments to JUS's investment process - running a more concentrated portfolio, a greater focus on selling underperforming holdings, while holding on to successful positions for longer - the trust has enjoyed an improvement in investment performance. It has delivered above market results in periods of both positive and negative stock market returns, illustrating its commitment to capital preservation. The board has also reduced JUS's management fees, removed the performance fee and introduced the trust's first gearing facility.

 

JUS's current 8.0% share price discount to cum-income NAV is narrower than the

averages of the last one and three years of 9.0% and 10.3% respectively, but wider

than the 7.2% and 6.7% averages of the last five and 10 years. The board actively

repurchases shares, aiming to ensure that the discount does not exceed 8% (in

normal market conditions). There is scope for the discount to narrow if the manager

continues to build on his improved recent investment performance.

 

Click here to view the full report.

 

All reports published by Edison are available to download free of charge from its website

www.edisoninvestmentresearch.com

About Edison: Edison is an investment research and advisory company, with offices in North America, Europe, the Middle East and AsiaPac. The heart of Edison is our world-renowned equity research platform and deep multi-sector expertise. At Edison Investment Research, our research is widely read by international investors, advisers and stakeholders. Edison Advisors leverages our core research platform to provide differentiated services including investor relations and strategic consulting.

Edison is authorised and regulated by the Financial Conduct Authority.

Edison is not an adviser or broker-dealer and does not provide investment advice. Edison's reports are not solicitations to buy or sell any securities.

For more information please contact Edison:

Mel Jenner, +44 (0)20 3077 5720

Sarah Godfrey, +44 (0)20 3681 2519

investmenttrusts@edisongroup.com

 

Learn more at www.edisongroup.com and connect with Edison on:

LinkedIn https://www.linkedin.com/company/edison-investment-research 

Twitter www.twitter.com/Edison_Inv_Res 

YouTube www.youtube.com/edisonitv 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
NRAEADSXFEEPEFF
Date   Source Headline
14th Dec 20205:13 pmRNSTransaction in Own Shares
14th Dec 202011:47 amRNSNet Asset Value(s)
11th Dec 20205:14 pmRNSTransaction in Own Shares
11th Dec 202011:21 amRNSNet Asset Value(s)
10th Dec 20205:22 pmRNSTransaction in Own Shares
10th Dec 20203:42 pmRNSHolding(s) in Company
10th Dec 202010:24 amRNSNet Asset Value(s)
9th Dec 20205:40 pmRNSTransaction in Own Shares
9th Dec 20209:52 amRNSKepler Trust Intelligence: Manager change analysis
9th Dec 20209:35 amRNSNet Asset Value(s)
9th Dec 20207:00 amRNSChange of Investment Manager
8th Dec 20209:47 amRNSNet Asset Value(s)
7th Dec 202010:16 amRNSNet Asset Value(s)
4th Dec 202011:17 amRNSNet Asset Value(s)
3rd Dec 202010:00 amRNSNet Asset Value(s)
2nd Dec 20209:54 amRNSNet Asset Value(s)
1st Dec 20204:21 pmRNSHolding(s) in Company
1st Dec 202011:26 amRNSNet Asset Value(s)
30th Nov 202010:43 amRNSNet Asset Value(s)
27th Nov 202011:24 amRNSNet Asset Value(s)
26th Nov 202010:01 amRNSNet Asset Value(s)
25th Nov 20209:45 amRNSNet Asset Value(s)
24th Nov 20209:41 amRNSNet Asset Value(s)
23rd Nov 202010:37 amRNSNet Asset Value(s)
20th Nov 202010:15 amRNSNet Asset Value(s)
19th Nov 202010:21 amRNSNet Asset Value(s)
18th Nov 202010:05 amRNSNet Asset Value(s)
17th Nov 20203:48 pmRNSPortfolio Update
17th Nov 202011:08 amRNSNet Asset Value(s)
16th Nov 20209:54 amRNSNet Asset Value(s)
13th Nov 202010:03 amRNSNet Asset Value(s)
12th Nov 202010:30 amRNSNet Asset Value(s)
11th Nov 202010:01 amRNSNet Asset Value(s)
10th Nov 202011:20 amRNSNet Asset Value(s)
9th Nov 20205:15 pmRNSTransaction in Own Shares
9th Nov 20209:52 amRNSNet Asset Value(s)
6th Nov 202012:13 pmRNSNet Asset Value(s)
5th Nov 202010:01 amRNSNet Asset Value(s)
4th Nov 20209:51 amRNSNet Asset Value(s)
3rd Nov 20205:17 pmRNSTransaction in Own Shares
3rd Nov 20209:39 amRNSNet Asset Value(s)
2nd Nov 20205:29 pmRNSTransaction in Own Shares
2nd Nov 202010:42 amRNSNet Asset Value(s)
30th Oct 20205:53 pmRNSTotal Voting Rights
30th Oct 202010:57 amRNSNet Asset Value(s)
29th Oct 202010:23 amRNSNet Asset Value(s)
28th Oct 202010:37 amRNSNet Asset Value(s)
27th Oct 202011:11 amRNSNet Asset Value(s)
26th Oct 20201:03 pmRNSDirector/PDMR Shareholding
26th Oct 20209:22 amRNSNet Asset Value(s)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.